Expression and purification of scFv
The expression and purification of the scFv followed the method described previously with minor modifications 2 . In brief, the scFv coding region was subcloned into pET-32 expression vector encoding thioredoxin as a fusion protein N-terminal to the scFv. The fusion protein contains a hexa-His tag followed by a TEV protease cutting site between the thioredoxin and the scFv, which is followed by an Avitag oligopeptide (GLNDIFEAQKIEWHE, Avidity Inc., USA) appending to the C- (Tris-HCl, 50 mM, pH 7.5, 400 mM NaCl, 10% glycerol). The soluble scFv protein was prepared with 95% purity. The purified sc-dsFv was stored at 4 o C for a least one week without affinity loss.
Construction and expression of IgG
VH and VL DNA fragments were PCR amplified separately. The VH and VL DNA fragments were assembled into the plasmid for IgG1 expression with the pIgG expression system (U.S. patent no. 5736137) with Gibson assembly cloning kit (NEB).
IgGs were expressed by 293F cells. 293F cells were subcultured to a final 1-1.5 x 10 6 cells/mL in Gibco® FreeStyle™ 293 Expression Medium (Invitrogen, cat. 12338), and incubated for 2-4 hrs at 37°C (8% CO2, 110 rpm). Each IgG construction was transfected into 293F cells with PEI (Polysciences Inc., cat. 24765) according to supplier's protocol. Expressed IgG was collected from cell culture supernatant 7-9 days or until cell viability drops below 60% after transfection. Protein A Sepharose (GE Healthcare, cat 17-0780-01) was reconstituted and packed as manufacture's instruction described. The 293F cell cultures were centrifuged and filtrated through 7 0.22 m filter. The IgG was purified through protein A column, eluted with 0.2 M glycine/HCl buffer, pH 2.5, and neutralized with 1 M Tris buffer, pH 9.0.
Antibody-antigen interaction affinity and kinetics measurements by surface plasmon resonance
BIAcore T200 (GE Healthcare) instrument was used to determine the binding 
IC 50 measurement
The half of maximal inhibitory concentration (IC50) was determined to evaluate neutralization ability of IgG. MDCK cells were seeded in 96-well plates and cultured for 16 hrs to confluency. Virus stock was freshly diluted by infection buffer. Purified
IgG diluted with PBS were mixed with 100 TCID50 viral solution for neutralization. CDRH1 library, the Template_1 primer was used to construct the template with stop codon (TAA) in the CDR-H1 region, and the library was diversified with the primer F10-CDRH1_1 over the template; for the F10-CDRH2 library, the Template_2 primer was used to construct the template, and the library was diversified with the primer F10-CDRH2_1 over the template; for the F10-CDRH3 library, the Template_3 primer was used to construct the template, and the library was diversified with the primer F10-CDRH3_1 over the template; for the F10-CDRH123 library, the Template_1~3 primers were used simultaneously to construct the template, and the library was diversified with the primer F10-CDRH123_1~3 simultaneously over the template. . Membrane-proximal epitopes   HA1  HA2  HA1  HA2  Subtype Number   40  42  292  49  52  56  18  38  19  20  21  22  23  41  45 Group1 
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